Renovaro Biosciences Inc. (RENB)

NASDAQ: RENB · IEX Real-Time Price · USD

1.530

-0.170 (-10.00%)

At close: Apr 26, 2024, 4:00 PM

1.480

-0.050 (-3.27%)

After-hours: Apr 26, 2024, 7:53 PM EDT

Renovaro Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-39.68	-113.43	-26.72	-11.42	-18.02	-6.31	-2.14
Depreciation & Amortization	0.11	0.12	0.12	0.37	0.07	0.02	0.01
Share-Based Compensation	3.54	5.49	1.44	1.03	2.16	0.28	0.98
Other Operating Activities	24.26	92.09	4.54	-0.44	7.27	1.67	-0.03
Operating Cash Flow	-11.77	-15.73	-20.61	-10.46	-8.51	-4.34	-1.18
Capital Expenditures	-0.03	-0.01	-0.05	-0.18	-0.72	-0.03	0
Acquisitions	0	0	0	0	0	-0.29	0
Change in Investments	0	0	0	0	0	-0.25	-0.2
Investing Cash Flow	-0.03	-0.01	-0.05	-0.18	-0.72	-0.58	-0.2
Share Issuance / Repurchase	5.64	4.81	33.15	1	6.02	16.71	3.51
Debt Issued / Paid	-1.12	-0.56	-0.55	6.2	0	0	2
Financing Cash Flow	4.52	4.25	32.6	7.2	6.02	16.71	5.51
Exchange Rate Effect	-0.01	-0.01	0.03	-0.14	0	0	0
Net Cash Flow	-7.3	-11.49	11.97	-3.59	-3.32	11.66	3.92
Free Cash Flow	-11.8	-15.74	-20.66	-10.64	-9.22	-4.37	-1.18
Free Cash Flow Per Share	-0.21	-0.30	-0.44	-0.23	-0.25	-0.20	-0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).